Subcutaneous cardioverter defibrillator has longer time to therapy but is less cardiotoxic than transvenous cardioverter defibrillator. Study carried out in a preclinical porcine model.
Garcia, Rodrigue
Subcutaneous cardioverter defibrillator has longer time to therapy but is less cardiotoxic than transvenous cardioverter defibrillator. Study carried out in a preclinical porcine model. [electronic resource] - Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 05 2018 - 873-879 p. digital
Publication Type: Comparative Study; Journal Article
1532-2092
10.1093/europace/eux074 doi
Animals
Creatine Kinase--analysis
Defibrillators, Implantable--adverse effects
Disease Models, Animal
Electric Countershock--adverse effects
Equipment Design
Swine
Treatment Outcome
Troponin T--analysis
Ventricular Fibrillation--therapy
Subcutaneous cardioverter defibrillator has longer time to therapy but is less cardiotoxic than transvenous cardioverter defibrillator. Study carried out in a preclinical porcine model. [electronic resource] - Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 05 2018 - 873-879 p. digital
Publication Type: Comparative Study; Journal Article
1532-2092
10.1093/europace/eux074 doi
Animals
Creatine Kinase--analysis
Defibrillators, Implantable--adverse effects
Disease Models, Animal
Electric Countershock--adverse effects
Equipment Design
Swine
Treatment Outcome
Troponin T--analysis
Ventricular Fibrillation--therapy